Clinical Trial Management Statistics


Steve Goldstein
Steve Goldstein
Business Formation Expert
Steve Goldstein runs LLCBuddy, helping entrepreneurs set up their LLCs easily. He offers clear guides, articles, and FAQs to simplify the process. His team keeps everything accurate and current, focusing on state rules, registered agents, and compliance. Steve’s passion for helping businesses grow makes LLCBuddy a go-to resource for starting and managing an LLC.

All Posts by Steve Goldstein →
Business Formation Expert  |   Fact Checked by Editorial Staff
Last updated: 
LLCBuddy™ offers informative content for educational purposes only, not as a substitute for professional legal or tax advice. We may earn commissions if you use the services we recommend on this site.
At LLCBuddy, we don't just offer information; we provide a curated experience backed by extensive research and expertise. Led by Steve Goldstein, a seasoned expert in the LLC formation sector, our platform is built on years of hands-on experience and a deep understanding of the nuances involved in establishing and running an LLC. We've navigated the intricacies of the industry, sifted through the complexities, and packaged our knowledge into a comprehensive, user-friendly guide. Our commitment is to empower you with reliable, up-to-date, and actionable insights, ensuring you make informed decisions. With LLCBuddy, you're not just getting a tutorial; you're gaining a trustworthy partner for your entrepreneurial journey.

Clinical Trial Management Statistics 2023: Facts about Clinical Trial Management outlines the context of what’s happening in the tech world.

LLCBuddy editorial team did hours of research, collected all important statistics on Clinical Trial Management, and shared those on this page. Our editorial team proofread these to make the data as accurate as possible. We believe you don’t need to check any other resources on the web for the same. You should get everything here only 🙂

Are you planning to form an LLC? Maybe for educational purposes, business research, or personal curiosity, whatever the reason is – it’s always a good idea to gather more information about tech topics like this.

How much of an impact will Clinical Trial Management Statistics have on your day-to-day? or the day-to-day of your LLC Business? How much does it matter directly or indirectly? You should get answers to all your questions here.

Please read the page carefully and don’t miss any words.

Top Clinical Trial Management Statistics 2023

☰ Use “CTRL+F” to quickly find statistics. There are total 10 Clinical Trial Management Statistics on this page 🙂

Clinical Trial Management “Latest” Statistics

  • Approximately 40% of clinical trials are supported by noncommercial sponsors, mostly academics, and the pharmaceutical sector funds 60%.[1]
  • 97% of those that responded and used new techniques for clinical trials during the pandemic said their organization would continue to use at least one of these new techniques.[2]
  • 58% of respondents, a small majority, said that their organizations intend to provide patients with the choice of how they participate in clinical studies.[2]
  • The COVID-19 pandemic, according to 76% of respondents in an industry poll conducted by Informa Pharma Intelligence and Oracle last year, has increased the use of decentralized clinical trial approaches.[2]
  • Most survey participants anticipate a rise in fit-for-purpose, hybrid, and/or decentralized clinical trial models in the future, 63% of whom expect these models to be utilized for both new studies and the restarts of current trials.[2]
  • Survey participants who used novel clinical trial techniques during the pandemic anticipated their organizations would utilize hybrid models more often (44%) and fit-for-purpose models more frequently (42%).[2]

Clinical Trial Management “Other” Statistics

  • The compliance rate increased between April 2019 and June 2022 from 24% to 64% for noncommercial sponsors to 77% to 86% for commercial sponsors.[1]
  • Among the four models: evaluated, site-based, fit-for-purpose, hybrid, and decentralized models, respondents expect a 24% drop in site usage.[2]
  • A whopping 87% of survey participants reported being able to utilize most or all of the extra data their recently deployed procedures have produced.[2]
  • 76% of responses were from biopharmaceutical businesses, while the remaining respondents were from medical device companies and CROs.[2]

Also Read

How Useful is Clinical Trial Management

One of the key aspects of clinical trial management is the careful selection and monitoring of participants. This ensures that the study sample is representative of the population to be treated, and controls for confounding variables that could skew results. It also helps in minimizing risks and ensuring the safety and ethical treatment of participants. By carefully managing the inclusion and exclusion criteria, researchers can ensure that the results of the trial are valid and applicable to the intended patient population.

In addition, clinical trial management involves rigorous protocol development and adherence to established guidelines and regulations. Protocols outline the objectives of the study, methods to be used, and procedures in place to ensure the safety of participants. By following these protocols, researchers can maintain scientific rigor and ensure that the study is conducted in a consistent and reproducible manner. This is critical for making informed decisions about the safety and efficacy of new treatments.

Another crucial aspect of clinical trial management is data management and analysis. Data collected during clinical trials must be accurately recorded, stored, and analyzed to discern the effects of the treatment being tested. This requires skilled professionals and advanced technology to ensure that the results are reliable and valid. By utilizing data management systems and statistical analysis, researchers can determine the efficacy and safety of new treatments, leading to evidence-based recommendations for patient care.

Furthermore, clinical trial management contributes to the overall knowledge and understanding of disease processes and treatment mechanisms. By testing new therapies in a controlled setting, researchers can identify new trends and advancements in the field of medicine. This knowledge helps in developing new treatments, refining existing ones, and improving patient outcomes. As such, clinical trial management is instrumental in driving healthcare innovation and advancing medical research.

Ultimately, the usefulness of clinical trial management cannot be overstated. It is the foundation of evidence-based medicine and plays a critical role in shaping the future of healthcare. By adhering to strict protocols, careful participant selection, and robust data management, researchers can generate reliable and applicable results that inform medical decision-making. As technology and knowledge continue to evolve, the importance of clinical trial management will only become more apparent in advancing patient care and improving health outcomes.

Reference

  1. europa – https://www.ema.europa.eu/en/human-regulatory/research-development/clinical-trials-human-medicines
  2. oracle – https://www.oracle.com/industries/life-sciences/clinical-research/clinical-trials-post-covid-research/

Leave a Comment